{
  "title": "Rethinking cancer of unknown primary: from diagnostic challenge to targeted treatment.",
  "pmid": "40759731",
  "doi": null,
  "affiliations": [
    "Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center (DKFZ) and Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany.",
    "Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany.",
    "Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center (DKFZ) and Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany.",
    "Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany.",
    "Department of Medical Oncology, Heidelberg University Hospital, Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.",
    "Department of Pathology and Molecular Pathology, University and University Hospital Zürich, Zürich, Switzerland.",
    "Medical Faculty, University of Zürich, Zürich, Switzerland.",
    "Department of Pathology and Molecular Pathology, University and University Hospital Zürich, Zürich, Switzerland.",
    "Medical Faculty, University of Zürich, Zürich, Switzerland.",
    "Institute of Pathology, University of Heidelberg, Heidelberg, Germany.",
    "Institute of Tumour Biology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.",
    "Institute of Pathology, University of Heidelberg, Heidelberg, Germany.",
    "Clinical Cooperation Unit Molecular Hematology/Oncology, German Cancer Research Center (DKFZ) and Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany. a.kraemer@dkfz.de.",
    "Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany. a.kraemer@dkfz.de."
  ]
}